CX3CR1 and neurodegenerative disease: SSC changes were consistent with CNS-myeloid cell morphological alterations observed in the hippocampus (Figure 2), and reduced CX3CR1 expression is related to the activated “damage associated microglia” (DAM) phenotype seen in neurodegenerative diseases (47).